Published procurement activity · 206 tenders
Buyer information published with procurement notices.
Uplift to total contract value
NHS Blood and Transplant (NHSBT) is inviting interested suppliers to take part in an early market engagement exercise for the provision of Direct Marketing, Print, and Fulfilment Services. This exercise aims to gather information on market capability, innovation, and indicative pricing to help shape a future procurement. NHSBT d
Delivery of a high-performing mailing and fulfilment service.
NHS Blood and Transplant (NHSBT) is seeking to engage with suppliers to inform the strategic development and potential future procurement of laboratory analyser platforms supporting routine and specialist testing. This Preliminary Market Engagement Notice invites suppliers to participate in market engagement sessions to present
As part of a preliminary market engagement exercise, NHS Blood & Transplant (NHSBT) are seeking to engage with suppliers of nucleic acids including plasmid DNA; synthetically produced DNA and/or enzymatically produced DNA. The intended use of the nucleic acids by NHSBT includes: a) the GMP grade production of gene therapy vector
NHS Blood and Transplant (NHSBT) have a requirement to hire equipment, both on a pre-planned and an emergency basis to support mobile collection sessions across the whole of England. This includes supplementary heating, lighting, and cooling equipment. NHSBT is responsible for collecting sufficient blood products to meet the dem
NHS Blood and Transplant's Clinical Biotechnology Centre (CBC) has a requirement for Custom-made and Designed Single-use, Disposable, Gamma Irradiated Consumables for GMP production within classified clean rooms. The CBC has an MHRA licence for the manufacture of sterile investigational medicinal gene therapy and recombinant pro
The Clinical Biotechnology Centre at the NHS Blood and Transplant is an MHRA licensed facility for the manufacture of investigational medical products such as advanced therapies and biotechnology products which includes plasmid DNA, viral vectors and therapeutic proteins. The organisation intends to initiate a procurement proces
NHS Blood and Transplant (NHSBT) invites expressions of interest from potential suppliers (of an existing product) or manufacturers capable of manufacturing any approved red cell storage solution, for example (but not limited to) SAG-M (Saline-Adenine-Glucose-Mannitol) or PAGGSM (Phosphate-Adenine-Glucose-Guanylate-Saline-Mannit
NHSBT would like to consult the market to establish the likely level of interest for the consumables and maintenance where Low Density Lipoprotein removal is performed on Fresenius Medical Care (UK) Ltd. ART Universal machines at the following sites: Bristol and Leeds. NHS Blood and Transplant (NHBST) is a Special Health Authori
Organisation details and tender classifications reflect information published by the original procurement sources. Similar buyer names are grouped only where an official identifier or compatible name and postcode provide a safe link.